object
review
evid
provid
recommend
antibiot
prophylaxi
obstetr
procedur
outcom
outcom
evalu
includ
need
effect
antibiot
prevent
infect
obstetr
procedur
publish
literatur
retriev
search
medlin
cochran
librari
topic
antibiot
prophylaxi
obstetr
procedur
result
restrict
systemat
review
random
control
trialscontrol
clinic
trial
observ
studi
search
updat
regular
basi
articl
publish
januari
june
incorpor
guidelin
current
guidelin
publish
american
colleg
obstetr
gynecolog
also
incorpor
grey
unpublish
literatur
identifi
search
websit
health
technolog
assess
health
technolog
assessmentrel
agenc
clinic
practic
guidelin
collect
clinic
trial
registri
nation
intern
medic
specialti
societi
nfectiou
complic
follow
obstetr
surgic
procedur
signific
sourc
morbid
potenti
mortal
includ
urinari
tract
infect
endometr
wound
infect
perin
infect
sepsi
lead
prolong
hospit
stay
increas
health
care
cost
much
work
done
studi
effect
prophylact
antibiot
reduc
infecti
morbid
plethora
antibiot
type
dose
schedul
rout
administr
investig
evid
support
use
prophylact
antibiot
number
procedur
obstetr
unfortun
compar
trial
conduct
leav
clinician
uncertainti
regimen
superior
presenc
antibiot
resist
organ
realiti
canadian
health
care
facil
organ
includ
methicillin
resist
staphylococcu
aureu
vancomycin
resist
enterococcu
extendedspectrum
betalactamaseproduc
organ
morbid
mortal
increas
infect
caus
organ
may
virul
difficult
treat
therapeut
option
limit
antibiot
resist
develop
result
mainli
inappropri
use
antibiot
incomplet
cours
antibiot
therapi
unnecessari
use
broader
spectrum
regimen
play
role
adher
treatment
prophylaxi
guidelin
like
assist
reduc
infect
antibiot
resist
physician
adher
antibiot
prophylaxi
guidelin
variabl
usual
odd
publish
guidelin
addit
antibiot
prophylaxi
essenti
review
factor
affect
infecti
risk
reduct
obstetr
care
adher
appropri
skin
prepar
procedur
includ
hair
clip
oppos
shave
effect
antisepsi
patient
staff
requir
steril
surgic
field
must
ensur
ongo
qualiti
assess
steril
techniqu
air
ventil
postop
wound
care
need
consist
infect
control
surveil
report
infecti
complic
track
abil
minim
morbid
possibl
identifi
cluster
infect
emerg
antibiot
resist
organ
dictat
chang
oper
routin
respond
evolv
microbi
divers
seem
inevit
septemb
jogc
septembr
l
purpos
antibiot
prophylaxi
surgic
procedur
steril
tissu
reduc
colon
pressur
microorgan
introduc
time
oper
level
patient
immun
system
abl
overcom
prophylaxi
prevent
infect
caus
postop
contamin
prophylact
antibiot
use
differ
treatment
antibiot
former
intend
prevent
infect
wherea
latter
intend
resolv
establish
infect
typic
requir
longer
cours
therapi
prophylaxi
intend
elect
procedur
incis
close
oper
room
agent
consid
use
prophylact
antibiot
must
evid
reduc
postop
infect
must
also
safe
inexpens
must
effect
organ
like
encount
surgic
procedur
agent
must
administ
way
ensur
serum
tissu
level
adequ
incis
made
therapeut
level
agent
maintain
serum
tissu
surgeri
hour
incis
close
wound
infectionssurg
site
infectionsin
form
cellul
abscess
dehisc
occur
follow
laparotomi
pelvic
infect
abscess
infect
hematoma
risk
surgic
procedur
enter
abdomin
caviti
cuff
cellul
specif
risk
hysterectomi
endometr
result
caesarean
section
surgic
abort
urinari
tract
infect
occur
result
procedur
involv
catheter
bladder
guidelin
publish
us
center
diseas
control
prevent
list
specif
stringent
criteria
must
met
diagnosi
surgic
site
infect
accur
surveil
ssi
monitor
requir
followup
day
postop
trend
toward
earli
discharg
hospit
make
surveil
challeng
estim
surgic
site
infect
occur
follow
discharg
hospit
prophylact
antibiot
given
administ
shortli
prior
bacteri
inocul
major
studi
suggest
singl
dose
effect
lengthi
procedur
hour
dose
repeat
interv
time
halflif
drug
also
suggest
larg
blood
loss
ml
second
dose
given
procedur
review
section
includ
caesarean
section
oper
vagin
deliveri
manual
remov
placenta
repair
third
fourth
degre
perin
lacer
cervic
cerclag
postpartum
dilat
curettag
recent
chang
endocard
prophylaxi
guidelin
also
review
singl
import
risk
factor
postpartum
matern
infect
caesarean
section
women
caesarean
section
greater
risk
infect
women
vagin
deliveri
rate
wound
infect
seriou
infecti
complic
high
consist
applic
definit
ssi
practic
postdischarg
surveil
vari
wide
debat
benefit
prophylact
antibiot
woman
elect
caesarean
section
intact
membran
without
labour
metaanalysi
studi
found
antibiot
prophylaxi
result
decreas
postop
fever
rr
ci
endometr
rr
ci
taken
togeth
data
support
recommend
use
prophylact
antibiot
women
undergo
caesarean
section
controversi
also
exist
whether
prophylact
antibiot
caesarean
section
given
prior
skin
incis
time
umbil
cord
clamp
tradit
prophylaxi
delay
effort
avoid
mask
neonat
infect
prevent
unnecessari
septic
workup
howev
recent
evid
may
chang
practic
random
trial
compar
matern
infecti
neonat
outcom
women
random
receiv
cefazolin
minut
incis
versu
cord
clamp
three
hundr
fiftyseven
women
enrol
overal
matern
infecti
morbid
reduc
pretreat
group
rr
ci
particular
endometr
reduc
rr
ci
increas
neonat
sepsi
investig
length
stay
observ
recent
metaanalysi
support
use
prophylact
antibiot
prior
caesarean
incis
prevent
total
infecti
morbid
rr
ci
p
neonat
outcom
affect
wide
studi
antibiot
surgic
prophylaxi
cephalosporin
cefazolin
firstgener
cephalosporin
pregnanc
categori
b
drug
given
intraven
halflif
hour
provid
good
coverag
gram
posit
organ
modest
gram
neg
coverag
guidelin
us
center
diseas
control
prevent
recommend
use
caesarean
section
recommend
gram
administ
intraven
minut
skin
cut
addit
dose
consid
blood
loss
exce
ml
hour
procedur
last
hour
ie
halfliv
drug
trial
shown
broader
spectrum
antibiot
caesarean
section
reduc
infecti
morbid
superior
trial
cefazolin
conduct
given
potenti
antibiot
resist
mother
neonat
recommend
use
broader
spectrum
antibiot
requir
studi
cochran
review
investig
use
prophylact
antibiot
oper
vagin
deliveri
either
forcep
vacuum
assist
deliveri
determin
prophylaxi
reduc
incid
postpartum
infect
review
identifi
one
trial
women
outcom
deem
appropri
review
assess
studi
endometr
length
hospit
stay
differ
receiv
prophylaxi
receiv
treatment
review
conclud
insuffici
data
base
recommend
practic
research
need
addit
studi
address
issu
publish
date
limit
inform
regard
use
prophylact
antibiot
reduc
develop
postpartum
endometr
follow
manual
remov
placenta
cochran
review
updat
april
identifi
random
control
trial
world
health
organ
suggest
prophylaxi
offer
recogn
direct
evid
valu
antibiot
prophylaxi
manual
remov
placenta
base
recommend
studi
involv
caesarean
section
abort
observ
studi
intrauterin
manipul
effect
oper
glove
chang
manual
remov
placenta
caesarean
section
studi
group
women
oper
chang
glove
one
half
case
differ
postcaesarean
endometr
note
group
howev
incid
endometr
decreas
placenta
deliv
spontan
rather
manual
remov
caesarean
section
studi
women
receiv
prophylact
antibiot
vs
rr
p
cochran
review
subject
found
random
trial
compar
prophylact
antibiot
placebo
treatment
fourth
degre
perin
tear
vagin
birth
welldesign
random
trial
recommend
undertaken
duggal
et
al
publish
prospect
trial
follow
women
post
third
fourth
degre
lacer
repair
week
women
randomli
assign
receiv
singl
intraven
dose
cefotetan
cefoxitin
placebo
four
receiv
antibiot
receiv
placebo
develop
perin
wound
complic
p
suggest
benefit
use
prophylact
antibiot
reduc
morbid
follow
signific
perin
lacer
insuffici
evid
support
use
prophylact
antibiot
placement
cervic
cerclag
clinic
set
one
studi
investig
use
continu
lowdos
antibiot
women
histori
second
trimest
pregnanc
loss
placement
cerclag
week
gestat
basi
transvagin
sonograph
find
cervic
funnel
patient
live
birth
pregnanc
prolong
mean
week
beyond
previou
pregnanc
control
group
second
retrospect
studi
midtrimest
cerclag
placement
antibiot
use
associ
decreas
risk
deliveri
week
gestat
random
clinic
trial
need
confirm
role
antibiot
highrisk
pregnanc
studi
identifi
investig
use
prophylact
antibiot
postpartum
dilat
curettag
increas
bmi
associ
higher
rate
obstetr
infecti
complic
control
trial
assess
requir
dosag
antibiot
prophylaxi
base
patient
bmi
assess
specialti
expert
opinion
recommend
twice
normal
dose
prophylaxi
morbidli
obes
patient
bmi
futur
research
area
need
penicillin
allergi
selfreport
patient
yet
actual
allerg
skin
test
perform
true
anaphylact
respons
penicillin
rare
occur
administr
allerg
reaction
cephalosporin
penicillin
allergi
occur
rate
altern
cephalosporin
given
individu
histori
penicillin
anaphylaxi
short
breath
evid
airway
edema
rather
rash
allerg
reaction
cephalosporin
allergi
altern
prophylact
antibiot
includ
clindamycin
mg
iv
erythromycin
mg
iv
american
heart
associ
guidelin
publish
found
evid
genitourinari
procedur
caus
ie
administr
antibiot
prevent
ie
follow
procedur
american
heart
associ
therefor
recommend
prophylact
antibiot
patient
undergo
genitourinari
procedur
chang
guidelin
identifi
condit
highest
risk
advers
outcom
tabl
patient
condit
list
tabl
establish
gastrointestin
genitourinari
tract
infect
receiv
antibiot
therapi
anoth
reason
eg
prevent
wound
infect
suggest
may
reason
choic
antibiot
also
activ
enterococci
ie
ampicillin
piperacillin
vancomycin
also
suggest
may
reason
patient
high
risk
ie
known
enterococc
urinari
tract
infect
colon
receiv
antibiot
treatment
prior
urinari
tract
manipul
review
recommend
chang
recent
publish
